The patient is receiving nitroglycerin 55 mcg/min.

Available: Nitroglycerin in 5% Dextrose Injection 25 mg per 250 mL (100 mcg/mL)

What is the flow rate?

A) Patients with hypertension
Low molecular weight heparin (LMWH) is not primarily used to treat hypertension. Hypertension (high blood pressure) is typically managed with antihypertensive medications like ACE inhibitors, beta-blockers, diuretics, or calcium channel blockers. LMWH is an anticoagulant, which works to prevent blood clots rather than controlling blood pressure.

B) Patients with asthma
LMWH is not typically used to treat asthma. Asthma is a chronic respiratory condition that is usually managed with bronchodilators (e.g., albuterol) and anti-inflammatory drugs such as corticosteroids. While patients with asthma may be at risk for blood clots under certain conditions (e.g., severe asthma exacerbations, immobility), LMWH is not a first-line treatment for asthma.

C) Patients with diabetes
While people with diabetes may be at an increased risk of developing blood clots, LMWH is not specifically used to treat diabetes. Diabetes is typically managed with insulin, oral hypoglycemic agents, lifestyle modifications, and other medications to control blood glucose levels. LMWH is an anticoagulant used for conditions that require prevention of clot formation, such as deep vein thrombosis (DVT).

D) Patients with deep vein thrombosis (DVT)
LMWH is commonly prescribed to patients with deep vein thrombosis (DVT). DVT occurs when a blood clot forms in a deep vein, usually in the legs. LMWH is a type of anticoagulant that prevents the formation of further clots by inhibiting factors involved in blood clotting. It is especially effective for patients with DVT or those at high risk for thromboembolic events, such as after surgery or during prolonged immobility. LMWH provides more predictable anticoagulation and requires less frequent monitoring than unfractionated heparin, making it ideal for outpatient management and in hospital settings.

Let's calculate the dosage using the provided information.

Information from the label:

Bumetanide concentration: 0.25 mg/mL

Available volume: 10 mL vial

Order: Bumex (bumetanide) 1 mg IV daily

Calculation:

Determine the desired dose: 1 mg

Use the formula:

Desired dose (mg) / Available concentration (mg/mL) = Volume to administer (mL)

Substitute the values:

1 mg / 0.25 mg/mL = Volume to administer (mL)

Calculate:

Volume to administer = 4 mL

Therefore, the correct answer is C. 4 mL